Denis G. Kay
Chief Scientific OfficerDr. Denis G. Kay, Ph.D., M.Sc., is Chief Scientific Officer at AlphaCognition, Inc (formerly known as Crystal Bridge Enterprises Inc.) since May 4, 2021. He serves as Chief Scientific Officer and Director of Alpha Cognition Inc. (formerly known as Neurodyn Life Sciences Inc.). He founded NLS in August 2006. Dr. Kay is Chief Scientific Officer of Neurodyn Inc. and holds an adjunct professorship in the Department of Pathology and Microbiology at the Atlantic Veterinary College at the University of Prince Edward Island. He is a grant recipient of the Michael J. Fox Foundation and has received funding from numerous agencies for research and product development programs. He has experience in the development and characterization of small animal models of human diseases ranging from, models of the neurodegenerative diseases ALS and the vacuolar myelopathy associated with HIV infection of the CNS, to a patented model of AIDS (co-inventor). He is also inventor on two families of Patents pending. He is a graduate of Dalhousie (B.Sc. and M.Sc.) and McGill (Ph.D.) Universities. He has contributed publications to over 40 scientific journals. Dr. Kay also held teaching assistantship positions at Dalhousie and McGill Universities and was a lecturer at McGill University.
Positions
- Company NameAlpha Cognition Inc.Stock CodeACOGPositionChief Scientific OfficerColleagues
- MEMichael E. McFaddenCEO & Director
- RJRobert James WillsIndependent Chairman of the Board
- KAKenneth Anthony CawkellFounder, Consultant, Corporate Secretary & Director
- HHHenry H. DuVP of Finance & Accounting and Interim CFO
- LDLauren D’AngeloChief Operating Officer
- PMPhillip MertzIndependent Director
- RKRajeev K. BakshiIndependent Director
